权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Serine Palmitoyl Transferase and Hereditary Neuropathy

丝氨酸棕榈酰转移酶与遗传性神经病

基本信息

批准号：
7341063
负责人：
TERESA M DUNN
金额：
$ 41.76万
依托单位：
HENRY M. JACKSON FDN FOR THE ADV MIL/MED
依托单位国家：
美国
项目类别：
财政年份：
2003
资助国家：
美国
起止时间：
2003-12-01 至 2010-11-30
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/7341063
关键词：
3-ketosphinganine reductase Alleles Anabolism Animal Model Apoptosis Behavioral Biochemical Biochemical Genetics Biological Models Biology Catabolism Catalysis Cell Cycle Progression Cell physiology Cells Ceramides Class Code Codon Nucleotides Collaborations Commit Complex Defect Development Disease Dominant-Negative Mutation Embryo Enzymes Epitopes Functional disorder Gene Expression Gene Silencing Genes Goals Hereditary Sensory Neuropathy Heterodimerization Heterozygote Homeostasis Homologous Gene Homozygote Human Knockout Mice Lead Lipids MALDI-TOF Mass Spectrometry Mammalian Cell Mammals Maps Mediating Membrane Membrane Microdomains Membrane Proteins Metabolism Microsomes Mining Molecular Mutation Neurons Organism Pathology Pathway interactions Peripheral Peripheral Nervous System Diseases Personal Satisfaction Phenotype Process Protein Overexpression Proteins Psyche structure Range Rate Regulation Reporting Research Personnel Role Saccharomyces cerevisiae Serine Signaling Molecule Sphingolipids Sphingosine Stream Structure Tissues Toxic effect Transferase Transgenic Mice Ursidae Family Work Yeasts base biological adaptation to stress clinically significant desaturase domain mapping hereditary neuropathy human disease inhibitor/antagonist mutant sensory neuropathy serine palmitoyltransferase tool yeast genetics yeast two hybrid system

项目摘要

DESCRIPTION (provided by applicant): Serine palmitoyltransferase (SPT) catalyzes the committed and rate-limiting step in sphingolipid synthesis. Mutations in the SPTLC1 gene, encoding the Sptlclp subunit of SPT, result in hereditary sensory neuropathy, type 1 (HSN1), the most common inherited neuropathy. Thus, aberrant sphingolipid synthesis may contribute to the pathophysiology of this disease. SPT contains at least one additional subunit, Sptlc2p, which forms a heterodimer with Sptlclp. HSN1 mutant Sptlclp proteins behave as dominant negative inhibitors of SPT activity by virtue of their ability to form catalytically inactive stable heterodimers. Our long-range goal is to identify the genes involved in sphingolipid synthesis and their role in human disease. Using a combination of model systems amenable to genetic and biochemical manipulation, we will determine how the mutations in SPT contribute to the pathophysiology of HSN1. Specifically we propose to: 1) isolate and characterize the mammalian SPT complex and identify the downstream components of the sphingosine biosynthetic pathway; 2) map the domains important for catalysis, heterodimerization, regulated Sptlc2p stability, and determine the topology of Sptlclp and Sptlc2p, and establish whether relocalization of SPT regulates activity; 3) elucidate the mechanism by which the HSN1 dominant negative mutations decrease SPT activity; and 4) construct transgenic mice expressing the SPTLC1-HSN1 dominant negative allele and an SPTLC1 "knock-out" mouse. SPT complexes will be immunopurified and their components identified by MALDI-TOF mass spectrometry. Two hybrid screens will be used to identify Sptlclp and Sptlc2p interacting proteins. Mapping of domains, determination of topology, intracellular localization, and characterization of dominant negative mutants will be performed using a combination of yeast genetics and expression of normal and mutant proteins in mammalian cells in which siRNAs are used to ablate endogenous gene expression. Mice transgenic for wildtype or mutant SPTLC1 will be characterized for behavioral, morphological, biochemical, and electrophysiological changes. Parallel analysis will be completed on SPTLC1 conditional knock-out mice. Taken together these studies will illuminate fundamental issues underlying the biology of sphingolipids, their regulation, and the disease process of HSN1.

描述（由申请人提供）：